J. Rerolle

发表

Clinical Pharmacokinetics and Bayesian Estimators for the Individual Dose Adjustment of a Generic Formulation of Tacrolimus in Adult Kidney Transplant Recipients

P. Marquet, N. Picard, H. Mazouz, 2020, Clinical Pharmacokinetics.

The clinical status and survival in elderly dialysis: example of the oldest region of France

Florence Glaudet, C. Couchoud, J. Aldigier, 2013, BMC Nephrology.

An unusual recurrence of crescentic nephritis after renal transplantation for IgA nephropathy.

E. Morelon, H. Kreis, L. Noël, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Opportunistic Infections and Efficacy Following Conversion to Belatacept-Based Therapy after Kidney Transplantation: A French Multicenter Cohort

L. Rostaing, E. Thervet, P. Gatault, 2020, Journal of clinical medicine.

Five‐Year Results of a Randomized Trial Comparing De Novo Sirolimus and Cyclosporine in Renal Transplantation: The Spiesser Study

O. Toupance, P. Deteix, Y. Lebranchu, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients

J. Achard, S. Hantz, S. Alain, 2021, Journal of the American Society of Nephrology : JASN.

One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial

O. Toupance, C. Pouteil‐Noble, P. Lang, 2016, Transplantation.

Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis.

E. Rondeau, A. Hertig, G. Nguyen, 2000, Kidney international.

Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant Recipients

A. Prémaud, P. Marquet, O. Toupance, 2009, Clinical pharmacokinetics.

Long-term successful outcome of sequential cardiac and allogeneic bone marrow transplantations in severe AL amyloidosis

G. Damaj, S. Varnous, M. Alyanakian, 2005, Bone Marrow Transplantation.

Population pharmacokinetics of gentamicin in haemodialysis patients: modelling, simulations and recommendations

P. Marquet, M. Essig, F. Saint‐Marcoux, 2020, European Journal of Clinical Pharmacology.

Absence of Mortality Differences Between the First and Second COVID-19 Waves in Kidney Transplant Recipients

N. Kamar, L. Frimat, P. Gatault, 2022, Kidney International Reports.

Incidence of cytomegalovirus infection in seropositive kidney transplant recipients treated with everolimus: A randomized, open‐label, multicenter phase 4 trial

N. Kamar, T. Bachelet, R. Thiébaut, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Cryptococcal Meningitis in Kidney Transplant Recipients: A Two-Decade Cohort Study in France

S. Ranque, L. Lachaud, Ophélie Fourdinier, 2022, Pathogens.

Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased‐donor kidney transplant recipients at specified risk of delayed graft function: 12‐month results of a randomized, multicenter trial

F. Berthoux, L. Rostaing, S. Quéré, 2010, Transplant international : official journal of the European Society for Organ Transplantation.

Incidence of Delayed Graft Function and Wound Healing Complications After Deceased-Donor Kidney Transplantation Is not Affected by De Novo Everolimus

F. Berthoux, L. Rostaing, O. Toupance, 2009, Transplantation.

Kidney transplantation in patients with systemic sclerosis: a nationwide multicentre study

A. Heng, N. Kamar, A. Durrbach, 2017, Transplant international : official journal of the European Society for Organ Transplantation.

2164 DE NOVO KIDNEY GRAFT TUMORS: RESULTS FROM A MULTICENTRIC RETROSPECTIVE NATIONAL STUDY

J. Patard, L. Salomon, J. Ferrière, 2010 .

Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10‐year postrandomization follow‐up study

J. Aldigier, M. Essig, B. Hurault de Ligny, 2016, Transplant international : official journal of the European Society for Organ Transplantation.

Presentation and revascularization outcomes in patients with radiation-induced renal artery stenosis.

P. Plouin, F. Fakhouri, A. Raynaud, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Veno-occlusive disease of the liver in renal transplant patients.

S. Pol, H. Fontaine, F. Larousserie, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Long-term renal allograft outcome after simultaneous kidney and pancreas transplantation.

E. Thervet, A. Janin, D. Nochy, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Donor P‐gp Polymorphisms Strongly Influence Renal Function and Graft Loss in a Cohort of Renal Transplant Recipients on Cyclosporine Therapy in a Long‐Term Follow‐Up

P. Marquet, N. Picard, M. Essig, 2010, Clinical pharmacology and therapeutics.

Donor Pgp polymorphisms strongly influence renal function and graft loss in a cohort of renal transplant recipients with long term follow-up

P. Marquet, N. Picard, Y. Meur, 2010 .

Donor P‐gp Polymorphisms Strongly Influence Renal Function and Graft Loss in a Cohort of Renal Transplant Recipients on Cyclosporine Therapy in a Long‐Term Follow‐Up

P. Marquet, N. Picard, Y. Meur, 2010, Clinical pharmacology and therapeutics.

Intracranial granuloma and skull osteolysis: complication of a primary cutaneous cryptococcosis in a kidney transplant recipient.

F. Paraf, J. Aldigier, Y. Le Meur, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Bordetella holmesii bacteremia in a renal transplant recipient: emergence of a new pathogen

J. Aldigier, M. Essig, O. Barraud, 2012, Transplant infectious disease : an official journal of the Transplantation Society.

Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients

P. Marquet, N. Picard, Y. Meur, 2007, Pharmacogenetics and genomics.

Multidrug resistance-associated protein 4 (MRP4) controls ganciclovir intracellular accumulation and contributes to ganciclovir-induced neutropenia in renal transplant patients.

P. Marquet, M. Otyepka, L. Rostaing, 2016, Pharmacological research.

Tacrolimus‐induced hemolytic uremic syndrome and end‐stage renal failure after liver transplantation

E. Rondeau, N. Lerolle, J. Sraer, 2000, Clinical transplantation.

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study.

C. Mengelle, L. Rostaing, Y. Lebranchu, 2010, The Journal of antimicrobial chemotherapy.

Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients.

H. Fleury, M. Essig, S. Alain, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.

F. Petitprez, Z. Massy, C. Charasse, 2019, Journal of the American Society of Nephrology : JASN.

Impact of targeted hypothermia in expanded-criteria organ donors on recipient kidney-graft function: study protocol for a multicentre randomised controlled trial (HYPOREME)

K. Asehnoune, L. Rostaing, A. Heng, 2022, BMJ Open.

HEMO2 life® improves renal function independent of cold ischemia time in kidney recipients: A comparison with a large multicenter prospective cohort study.

F. Zal, M. Büchler, L. Badet, 2021, Artificial organs.

Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: Results of a nationwide study

F. Martinez, C. Lambert, J. Aniort, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF—Four‐Year Results of the Postconcept Study

E. Thervet, O. Toupance, Y. Lebranchu, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)

J. Dumortier, A. Heng, N. Kamar, 2020, Kidney International.

Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele.

P. Marquet, N. Picard, M. Essig, 2010, British journal of clinical pharmacology.

Adherence profiles in kidney transplant patients: Causes and consequences.

P. Marquet, N. Kamar, M. Essig, 2019, Patient education and counseling.

Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients.

Y. Le Meur, J. Rerolle, J. Szelag, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Individualized Mycophenolate Mofetil Dosing Based on Drug Exposure Significantly Improves Patient Outcomes After Renal Transplantation

P. Marquet, L. Rostaing, E. Thervet, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study.

J. Dumortier, J. Izopet, R. D. de Man, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Kaposi Sarcoma in HIV-positive Solid-Organ Transplant Recipients: A French Multicentric National Study and Literature Review

C. Lebbé, D. Glotz, A. Coilly, 2019, Transplantation.

Genome‐Wide Association Study of Acute Renal Graft Rejection

M. Georges, D. Abramowicz, M. Abramowicz, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.

R. Porcher, A. Heng, O. Toupance, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PAI-1 donor polymorphism influences long-term kidney graft survival.

P. Preux, J. Aldigier, Y. Le Meur, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

De Novo Kidney Graft Tumors: Results From a Multicentric Retrospective National Study

J. Patard, L. Salomon, F. Kleinclauss, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

TCF7L2 polymorphism associates with new-onset diabetes after transplantation.

D. Abramowicz, M. Abramowicz, K. Wissing, 2009, Journal of the American Society of Nephrology : JASN.

Crescentic glomerulonephritis and centrocytic lymphoma.

E. Thervet, C. Legendre, E. Pillebout, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Chronic Hepatitis C Virus Infection After Kidney Transplantation With or Without Direct-Acting Antivirals in a Real-Life Setting: A French Multicenter Experience.

L. Rostaing, P. Gatault, M. Büchler, 2020, Transplantation proceedings.

New clinical forms of hereditary apoA-I amyloidosis entail both glomerular and retinal amyloidosis.

N. Rioux-Leclercq, D. Samuel, F. Paraf, 2020, Kidney international.

Molecular basis for a novel systemic form of human hereditary apoA-I amyloidosis with vision loss

J. Straub, N. Rioux-Leclercq, F. Paraf, 2018, bioRxiv.

Characteristics of T- and NK-cell Lymphomas After Renal Transplantation: A French National Multicentric Cohort Study

P. Gaulard, G. Salles, P. Rieu, 2021, Transplantation.

Acute renal failure following allogeneic hematopoietic cell transplantation: incidence, outcome and risk factors.

I. Helal, H. Kreis, J. Rerolle, 2011, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

Pharmacokinetic Therapeutic Drug Monitoring of Advagraf in More Than 500 Adult Renal Transplant Patients, Using an Expert System Online

P. Marquet, N. Kamar, M. Essig, 2018, Therapeutic drug monitoring.

A Lack of Significant Effect of POR*28 Allelic Variant on Tacrolimus Exposure in Kidney Transplant Recipients

M. Loriot, P. Beaune, G. Choukroun, 2016, Therapeutic drug monitoring.

Eight‐year results of the Spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation

A. Heng, P. Gatault, Y. Lebranchu, 2016, Transplant international : official journal of the European Society for Organ Transplantation.

An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants

J. Dumortier, A. Heng, N. Kamar, 2020, Kidney International.

Successful endoluminal thromboaspiration of renal graft venous thrombosis.

C. Antoine, D. Glotz, B. Beyssen, 2000, Transplantation Proceedings.

Successful endoluminal thrombo‐aspiration of renal graft venous thrombosis

C. Antoine, D. Glotz, B. Beyssen, 2000 .

Parvovirus B19-related Anaemia After Renal Transplantation

I. Helal, M. Mamzer-Bruneel, E. Morelon, 2004, Scandinavian journal of infectious diseases.

Early Steroid Withdrawal and Optimization of Mycophenolic Acid Exposure in Kidney Transplant Recipients Receiving Mycophenolate Mofetil

F. Vrtovsnik, A. Heng, F. Glowacki, 2011, Transplantation.

Occurrence of severe COVID-19 in vaccinated transplant patients

N. Kamar, P. Gatault, H. François, 2021, Kidney International.

Thrombotic Microangiopathy and Hypothermia in an HIV-positive Patient: Importance of Cytomegalovirus Infection

G. Canaud, E. Morelon, H. Kreis, 2004, Scandinavian journal of infectious diseases.

CYP3A5*3 influences sirolimus oral clearance in de novo and stable renal transplant recipients

P. Marquet, O. Toupance, Y. Meur, 2006, Clinical pharmacology and therapeutics.

Sirolimus Population Pharmacokinetic/Pharmacogenetic Analysis and Bayesian Modelling in Kidney Transplant Recipients

P. Marquet, O. Toupance, Y. Meur, 2006, Clinical pharmacokinetics.

Paternity in male kidney transplant recipients: a French national survey, the PATeRNAL study

E. Thervet, D. Anglicheau, B. Hurault de Ligny, 2020, BMC Nephrology.

Opportunistic infections after conversion to belatacept in kidney transplantation.

P. Gatault, I. Étienne, A. Thierry, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A candidate gene approach of the calcineurin pathway to identify variants associated with clinical outcomes in renal transplantation.

P. Marquet, L. Rostaing, N. Kamar, 2016, Pharmacogenomics.

Conversion from everolimus with low-exposure cyclosporine to everolimus with mycophenolate sodium maintenance therapy in kidney transplant recipients: a randomized, open-label multicenter study.

S. Quéré, O. Toupance, N. Kamar, 2012, Annals of transplantation.

Impact of longitudinal exposure to mycophenolic acid on acute rejection in renal-transplant recipients using a joint modeling approach.

D. Rizopoulos, A. Prémaud, P. Marquet, 2013, Pharmacological research.

Torque teno virus viremia and QuantiFERON®-CMV assay in prediction of cytomegalovirus reactivation in R+ kidney transplant recipients

A. Labrunie, M. Essig, B. Janbon, 2023, Frontiers in Medicine.

Severe sirolimus‐induced acute hepatitis in a renal transplant recipient

J. Aldigier, M. Essig, P. Carrier, 2010, Transplant international : official journal of the European Society for Organ Transplantation.

An unusual pulmonary complication of cytomegalovirus infection in a renal transplant recipient

J. Aldigier, M. Essig, A. Dallocchio, 2008, NDT plus.

Evaluation of the efficacy of HEMO2life®, a marine OXYgen carrier for Organ Preservation (OxyOp2) in renal transplantation: study protocol for a multicenter randomized trial

N. Kamar, F. Zal, J. Dantal, 2023, Trials.

Merkel cell carcinoma from renal transplant recipients are mostly MCPyV‐negative and are frequently associated with squamous cell carcinomas or precursors

L. Doucet, C. Collin, P. Gatault, 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.

Changing of therapeutic trends between the 1st and 2nd wave did not reduce COVID-19 related mortality of renal transplant recipients: a national registry study.

N. Kamar, L. Frimat, P. Gatault, 2021, medRxiv.

Clinical Utility of Biochemical Markers for the Prediction of COVID-19−Related Mortality in Kidney Transplant Recipients

J. Dumortier, A. Heng, N. Kamar, 2021, Kidney International Reports.

New perspectives for the therapeutic drug monitoring of tacrolimus: Quantification in volumetric DBS based on an automated extraction and LC-MS/MS analysis.

P. Marquet, F. Saint‐Marcoux, C. Monchaud, 2023, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Population pharmacokinetics of gentamicin in haemodialysis patients: modelling, simulations and recommendations

P. Marquet, M. Essig, F. Saint‐Marcoux, 2020, European Journal of Clinical Pharmacology.

A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry.

P. Marquet, L. Gastinel, Y. Meur, 2008, BMC genomics.

Therapeutic education as a tool to improve patient‐reported and clinical outcomes after renal transplantation: results of the EPHEGREN multicenter retrospective cohort study

P. Marquet, N. Kamar, I. Étienne, 2021, Transplant international : official journal of the European Society for Organ Transplantation.